ID   CLIP1_RAT               Reviewed;        1320 AA.
AC   Q9JK25; A0A0G2K3T3;
DT   30-NOV-2016, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2016, sequence version 2.
DT   02-OCT-2024, entry version 140.
DE   RecName: Full=CAP-Gly domain-containing linker protein 1;
DE   AltName: Full=Cytoplasmic linker protein 170 {ECO:0000303|PubMed:11290329, ECO:0000303|PubMed:20519438, ECO:0000303|PubMed:26972003};
DE            Short=CLIP-170 {ECO:0000303|PubMed:11290329, ECO:0000303|PubMed:20519438, ECO:0000303|PubMed:26972003};
DE   AltName: Full=Restin;
GN   Name=Clip1; Synonyms=Cyln1, Rsn;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Hippocampus;
RX   PubMed=11290329; DOI=10.1016/s0092-8674(01)00288-4;
RA   Akhmanova A., Hoogenraad C.C., Drabek K., Stepanova T., Dortland B.,
RA   Verkerk T., Vermeulen W., Burgering B.M., de Zeeuw C.I., Grosveld F.,
RA   Galjart N.;
RT   "Clasps are CLIP-115 and -170 associating proteins involved in the regional
RT   regulation of microtubule dynamics in motile fibroblasts.";
RL   Cell 104:923-935(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   PHOSPHORYLATION AT SER-309; SER-311; SER-314 AND SER-347, MUTAGENESIS OF
RP   SER-309; SER-311; SER-313; SER-319 AND SER-320, AND INTERACTION WITH DCTN1.
RX   PubMed=20519438; DOI=10.1091/mbc.e09-12-1036;
RA   Lee H.S., Komarova Y.A., Nadezhdina E.S., Anjum R., Peloquin J.G.,
RA   Schober J.M., Danciu O., van Haren J., Galjart N., Gygi S.P., Akhmanova A.,
RA   Borisy G.G.;
RT   "Phosphorylation controls autoinhibition of cytoplasmic linker protein-
RT   170.";
RL   Mol. Biol. Cell 21:2661-2673(2010).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-194; SER-199; SER-203;
RP   SER-309; SER-1116 AND SER-1246, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [5]
RP   PHOSPHORYLATION, SUBCELLULAR LOCATION, MUTAGENESIS OF SER-309; SER-311;
RP   SER-313; SER-319 AND SER-320, INTERACTION WITH DCTN1, AND ASSOCIATION WITH
RP   MICROTUBULES.
RX   PubMed=26972003; DOI=10.1016/j.celrep.2016.02.046;
RA   Nirschl J.J., Magiera M.M., Lazarus J.E., Janke C., Holzbaur E.L.;
RT   "Alpha-tubulin tyrosination and CLIP-170 phosphorylation regulate the
RT   initiation of dynein-driven transport in neurons.";
RL   Cell Rep. 14:2637-2652(2016).
CC   -!- FUNCTION: Binds to the plus end of microtubules and regulates the
CC       dynamics of the microtubule cytoskeleton. Promotes microtubule growth
CC       and microtubule bundling. Links cytoplasmic vesicles to microtubules
CC       and thereby plays an important role in intracellular vesicle
CC       trafficking. Plays a role macropinocytosis and endosome trafficking.
CC       {ECO:0000250|UniProtKB:P30622}.
CC   -!- SUBUNIT: Interacts with MTOR; phosphorylates and regulates CLIP1.
CC       Interacts (via CAP-Gly domains) with tubulin and TUBA1B. Interacts with
CC       SLAIN2. Interacts with MAPRE1 and MAPRE3 (By similarity). Interacts
CC       (via zinc finger) with DCTN1 (PubMed:20519438, PubMed:26972003). Binds
CC       preferentially to tyrosinated microtubules, and only marginally to
CC       detyrosinated microtubules (PubMed:26972003).
CC       {ECO:0000250|UniProtKB:P30622, ECO:0000269|PubMed:20519438,
CC       ECO:0000269|PubMed:26972003}.
CC   -!- INTERACTION:
CC       Q9JK25; Q7Z460: CLASP1; Xeno; NbExp=2; IntAct=EBI-908338, EBI-913476;
CC       Q9JK25; P67870: CSNK2B; Xeno; NbExp=2; IntAct=EBI-908338, EBI-348169;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P30622}.
CC       Cytoplasm, cytoskeleton {ECO:0000269|PubMed:26972003}. Cytoplasmic
CC       vesicle membrane {ECO:0000250|UniProtKB:P30622}; Peripheral membrane
CC       protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Cell projection,
CC       ruffle {ECO:0000250|UniProtKB:P30622}. Note=Localizes to microtubule
CC       plus ends. Localizes preferentially to the ends of tyrosinated
CC       microtubules (PubMed:26972003). Accumulates in plasma membrane regions
CC       with ruffling and protrusions. Associates with the membranes of
CC       intermediate macropinocytic vesicles (By similarity).
CC       {ECO:0000250|UniProtKB:P30622, ECO:0000269|PubMed:26972003}.
CC   -!- DOMAIN: Intramolecular interaction between the zinc finger domain and
CC       the CAP-Gly domains may inhibit interaction with tubulin.
CC       {ECO:0000250|UniProtKB:P30622}.
CC   -!- PTM: Phosphorylated. Phosphorylation induces conformational changes by
CC       increasing the affinity of the N-terminus for C-terminus, resulting in
CC       inhibition of its function thus decreasing its binding to microtubules
CC       and DCTN1. Exhibits a folded, autoinhibited conformation when
CC       phosphorylated and an open conformation when dephosphorylated with
CC       increased binding affinity to microtubules and DCTN1. Phosphorylation
CC       regulates its recruitment to tyrosinated microtubules and the
CC       recruitment of vesicular cargo to microtubules in neurons
CC       (PubMed:20519438, PubMed:26972003). Phosphorylation by MTOR may
CC       positively regulate CLIP1 association with microtubules (By
CC       similarity). {ECO:0000250|UniProtKB:P30622,
CC       ECO:0000269|PubMed:20519438, ECO:0000269|PubMed:26972003}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ237670; CAB92974.1; -; mRNA.
DR   EMBL; AC117299; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_113933.2; NM_031745.2.
DR   AlphaFoldDB; Q9JK25; -.
DR   SMR; Q9JK25; -.
DR   IntAct; Q9JK25; 9.
DR   MINT; Q9JK25; -.
DR   STRING; 10116.ENSRNOP00000073711; -.
DR   iPTMnet; Q9JK25; -.
DR   PhosphoSitePlus; Q9JK25; -.
DR   jPOST; Q9JK25; -.
DR   PaxDb; 10116-ENSRNOP00000001685; -.
DR   Ensembl; ENSRNOT00000001685.8; ENSRNOP00000001685.8; ENSRNOG00000001247.8.
DR   Ensembl; ENSRNOT00055025456; ENSRNOP00055020776; ENSRNOG00055014674.
DR   Ensembl; ENSRNOT00060004846; ENSRNOP00060003507; ENSRNOG00060002932.
DR   Ensembl; ENSRNOT00065009597; ENSRNOP00065006906; ENSRNOG00065006227.
DR   GeneID; 65201; -.
DR   KEGG; rno:65201; -.
DR   UCSC; RGD:67404; rat.
DR   AGR; RGD:67404; -.
DR   CTD; 6249; -.
DR   RGD; 67404; Clip1.
DR   eggNOG; KOG4568; Eukaryota.
DR   GeneTree; ENSGT00940000155122; -.
DR   InParanoid; Q9JK25; -.
DR   OrthoDB; 2914056at2759; -.
DR   PhylomeDB; Q9JK25; -.
DR   Reactome; R-RNO-141444; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal.
DR   Reactome; R-RNO-2467813; Separation of Sister Chromatids.
DR   Reactome; R-RNO-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-RNO-5626467; RHO GTPases activate IQGAPs.
DR   Reactome; R-RNO-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-RNO-68877; Mitotic Prometaphase.
DR   Reactome; R-RNO-9648025; EML4 and NUDC in mitotic spindle formation.
DR   PRO; PR:Q9JK25; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   Bgee; ENSRNOG00000001247; Expressed in esophagus and 19 other cell types or tissues.
DR   ExpressionAtlas; Q9JK25; baseline and differential.
DR   GO; GO:0005938; C:cell cortex; IBA:GO_Central.
DR   GO; GO:0005813; C:centrosome; ISO:RGD.
DR   GO; GO:0005881; C:cytoplasmic microtubule; IDA:UniProtKB.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0044354; C:macropinosome; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005874; C:microtubule; ISO:RGD.
DR   GO; GO:0015630; C:microtubule cytoskeleton; ISO:RGD.
DR   GO; GO:0035371; C:microtubule plus-end; IDA:UniProtKB.
DR   GO; GO:0005635; C:nuclear envelope; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0001726; C:ruffle; IEA:UniProtKB-SubCell.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0051010; F:microtubule plus-end binding; IDA:UniProtKB.
DR   GO; GO:0015631; F:tubulin binding; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; ISO:RGD.
DR   GO; GO:0031122; P:cytoplasmic microtubule organization; IBA:GO_Central.
DR   GO; GO:0001578; P:microtubule bundle formation; ISO:RGD.
DR   GO; GO:1900006; P:positive regulation of dendrite development; IMP:RGD.
DR   GO; GO:0031116; P:positive regulation of microtubule polymerization; ISO:RGD.
DR   GO; GO:0044861; P:protein transport into plasma membrane raft; ISO:RGD.
DR   Gene3D; 2.30.30.190; CAP Gly-rich-like domain; 2.
DR   Gene3D; 1.20.5.1160; Vasodilator-stimulated phosphoprotein; 1.
DR   InterPro; IPR036859; CAP-Gly_dom_sf.
DR   InterPro; IPR000938; CAP-Gly_domain.
DR   InterPro; IPR032108; CLIP1_ZNF.
DR   PANTHER; PTHR18916:SF44; CAP-GLY DOMAIN-CONTAINING LINKER PROTEIN 1; 1.
DR   PANTHER; PTHR18916; DYNACTIN 1-RELATED MICROTUBULE-BINDING; 1.
DR   Pfam; PF01302; CAP_GLY; 2.
DR   Pfam; PF16641; CLIP1_ZNF; 2.
DR   SMART; SM01052; CAP_GLY; 2.
DR   SUPFAM; SSF74924; Cap-Gly domain; 2.
DR   PROSITE; PS00845; CAP_GLY_1; 2.
DR   PROSITE; PS50245; CAP_GLY_2; 2.
PE   1: Evidence at protein level;
KW   Cell projection; Coiled coil; Cytoplasm; Cytoplasmic vesicle; Cytoskeleton;
KW   Membrane; Metal-binding; Microtubule; Phosphoprotein; Reference proteome;
KW   Repeat; Transport; Zinc; Zinc-finger.
FT   CHAIN           1..1320
FT                   /note="CAP-Gly domain-containing linker protein 1"
FT                   /id="PRO_0000438322"
FT   DOMAIN          78..120
FT                   /note="CAP-Gly 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00045"
FT   DOMAIN          231..273
FT                   /note="CAP-Gly 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00045"
FT   ZN_FING         1299..1316
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000250|UniProtKB:P30622"
FT   REGION          1..53
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          97..101
FT                   /note="Important for tubulin binding"
FT                   /evidence="ECO:0000250|UniProtKB:P30622"
FT   REGION          156..181
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          301..338
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1089..1109
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1178..1201
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        304..338
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1092..1109
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         48
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P30622"
FT   MOD_RES         50
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P30622"
FT   MOD_RES         146
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P30622"
FT   MOD_RES         181
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P30622"
FT   MOD_RES         194
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         196
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P30622"
FT   MOD_RES         199
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         203
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         309
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20519438,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         311
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:20519438"
FT   MOD_RES         314
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20519438"
FT   MOD_RES         347
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20519438"
FT   MOD_RES         1116
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1246
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MUTAGEN         309
FT                   /note="S->A: Phosphodeficient mutant which exhibits an open
FT                   conformation with a high affinity for microtubules and
FT                   DCTN1; when associated with A-311; A-313; A-319 and A-320."
FT                   /evidence="ECO:0000269|PubMed:20519438,
FT                   ECO:0000269|PubMed:26972003"
FT   MUTAGEN         309
FT                   /note="S->E: Phosphomimetic mutant which exhibits a closed
FT                   autoinhibited conformation with a low affinity for
FT                   microtubules and DCTN1; when associated with E-311; E-313;
FT                   E-319 and E-320."
FT                   /evidence="ECO:0000269|PubMed:20519438,
FT                   ECO:0000269|PubMed:26972003"
FT   MUTAGEN         311
FT                   /note="S->A: Phosphodeficient mutant which exhibits an open
FT                   conformation with a high affinity for microtubules and
FT                   DCTN1; when associated with A-309; A-313; A-319 and A-320."
FT                   /evidence="ECO:0000269|PubMed:20519438,
FT                   ECO:0000269|PubMed:26972003"
FT   MUTAGEN         311
FT                   /note="S->E: Phosphomimetic mutant which exhibits a closed
FT                   autoinhibited conformation with a low affinity for
FT                   microtubules and DCTN1; when associated with E-309; E-313;
FT                   E-319 and E-320."
FT                   /evidence="ECO:0000269|PubMed:20519438,
FT                   ECO:0000269|PubMed:26972003"
FT   MUTAGEN         313
FT                   /note="S->A: Phosphodeficient mutant which exhibits an open
FT                   conformation with a high affinity for microtubules and
FT                   DCTN1; when associated with A-309; A-311; A-319 and A-320."
FT                   /evidence="ECO:0000269|PubMed:20519438,
FT                   ECO:0000269|PubMed:26972003"
FT   MUTAGEN         313
FT                   /note="S->E: Phosphomimetic mutant which exhibits a closed
FT                   autoinhibited conformation with a low affinity for
FT                   microtubules and DCTN1; when associated with E-309; E-311;
FT                   E-319 and E-320."
FT                   /evidence="ECO:0000269|PubMed:20519438,
FT                   ECO:0000269|PubMed:26972003"
FT   MUTAGEN         319
FT                   /note="S->A: Phosphodeficient mutant which exhibits an open
FT                   conformation with a high affinity for microtubules and
FT                   DCTN1; when associated with A-309; A-311; A-313 and A-320."
FT                   /evidence="ECO:0000269|PubMed:20519438,
FT                   ECO:0000269|PubMed:26972003"
FT   MUTAGEN         319
FT                   /note="S->E: Phosphomimetic mutant which exhibits a closed
FT                   autoinhibited conformation with a low affinity for
FT                   microtubules and DCTN1; when associated with E-30; E-311;
FT                   E-313 and E-320."
FT                   /evidence="ECO:0000269|PubMed:20519438,
FT                   ECO:0000269|PubMed:26972003"
FT   MUTAGEN         320
FT                   /note="S->A: Phosphodeficient mutant which exhibits an open
FT                   conformation with a high affinity for microtubules and
FT                   DCTN1; when associated with A-309; A-311; A-313 and A-319."
FT                   /evidence="ECO:0000269|PubMed:20519438,
FT                   ECO:0000269|PubMed:26972003"
FT   MUTAGEN         320
FT                   /note="S->E: Phosphomimetic mutant, exhibits a closed
FT                   autoinhibited conformation with a low affinity for
FT                   microtubules and DCTN1; when associated with E-309; E-311;
FT                   E-313 and E-319."
FT                   /evidence="ECO:0000269|PubMed:20519438,
FT                   ECO:0000269|PubMed:26972003"
FT   CONFLICT        1232
FT                   /note="A -> G (in Ref. 1; CAB92974)"
SQ   SEQUENCE   1320 AA;  148279 MW;  81D8096405D4689D CRC64;
     MSMLKPSGLK APTKILKPGS TALKTPAAAA APLEKTVPSE KASGPPSSET QEEFVDDFRV
     GERVWVNGNK PGFIQFLGET QFAPGQWAGI VLDEPIGKND GSVAGVRYFQ CEPLKGIFTR
     PSKLTRKVQA EDEANGLQTA HARAASPLST AAATMVSSSP ATPSNIPQKP SQPVAKETSA
     TPQISNLTKT ASESISNLSE AGSVKKGERE LKIGDRVLVG GTKAGVVRFL GETDFAKGEW
     CGVELDEPLG KNDGAVAGTR YFQCQPKYGL FAPVHKVTKI GFPSTTPAKA KAAAVRRVMA
     TTPASLKRSP SASSLSSMSS VASSVSSKPS RTGLLTETSS RYARKISGTT ALQEALKEKQ
     QHIEQLLAER DLERAEVAKA TSHVGEIEQE LALARDGHDQ HVLELEAKMD QLRTMVEAAD
     REKVELLNQL EEEKRKVEDL QFRVEEESIT KGDLETQTKL EHARIKELEQ SLLFEKTKAD
     KLQRELEDTR VATVSEKSRI MELEKDLALR VQEVAELRRR LESSKPPGDV DMSLSLLQEI
     SALQEKLEVT HTDHQNEVTS LKDHFGTREE MFQKEIKALH AATEKLSKEN ESLRSKLDHA
     NKENSDVIAL WKSKLETAIA SHQQAMEELK VSFSKGIGTD SAEFAELKTQ IERLRLDYQH
     EIESLQSKQD SERSAHAKEM ESMKAKLMKI IKEKEDSLEA VKARLDTAED QHLVEMEEML
     SKLQEAEIKK EKFASASEEA VSTQTSMQDT VNKLHQKEEQ FNMLSSELEK LRENLTDMEA
     KFKEKDERED QLVKAKEKLE NDIAEIMKMS GDNSSQLTKM NDELRLKERS VEELQLKLTK
     ANENASLLQK SIGEVTLKAE QSQQEAAKKH EEEKKELENK LLELEKKMET SHYQCQDLKA
     KYEKASSETK IKHEEILQNF QKMLVDTEDK LKAAQEANRD LMQDMEELKS QADKAKAAQT
     AEDAMQIMEQ MTKEKTETLA SLEDTKQTNA KLQSELDTLK ENNLKTVEEL NKSKELLNEE
     NQKMEEFKKE IETLKQAAAQ KSQQLSALQE ENVKLAEELG RTRDEVTSHQ KLEEERSVLN
     NQLLEMKKSL PSNTLRESEY RKDADEEKAS LQKSISLTSA LLTEKDAELE KLRNEVTVLR
     GENASAKSLH SVVQTLESDK VKLELKVKNL ELQLKENKRQ LSSSSGNTDV QTEEDERAQE
     SQQMIDFLNS VIVDLQRKNQ DLKMKVEMMS EAALNGNGED PNSYDSDDQE KQSKKKPRLF
     CDICDCFDLH DTEDCPTQAQ MSEDPPHSTH HGSRSEERPY CEICEMFGHW ATNCNDDETF
//
